SIGN UP
FDA's approval of Biostage's first IND is an extremely important milestone for Biostage as it will transition Biostage into a clinical stage company. >>>
Approximately 1 in 4,000 babies, in the US alone, are born with this congenital defect. Find out how Biostage is working to answer this unmet medical need. >>>
This website use cookies to facilitate the use of the website, improve its performance and security, personalize the proposed content. To learn more about how we treat your data, visit our Privacy policy